1 Study Coverage 1.1 Hepatitis B Vaccine (Recombinant) Product Introduction 1.2 Market by Type 1.2.1 Global Hepatitis B Vaccine (Recombinant) Market Size Growth Rate by Type 1.2.2 10mcg/0.5ml 1.2.3 10mcg/ml 1.3 Market by Application 1.3.1 Global Hepatitis B Vaccine (Recombinant) Market Size Growth Rate by Application 1.3.2 Newborn 1.3.3 Adult 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Hepatitis B Vaccine (Recombinant) Market Size, Estimates and Forecasts 2.1.1 Global Hepatitis B Vaccine (Recombinant) Revenue 2016-2027 2.1.2 Global Hepatitis B Vaccine (Recombinant) Sales 2016-2027 2.2 Global Hepatitis B Vaccine (Recombinant), Market Size by Region: 2016 VS 2021 VS 2027 2.3 Hepatitis B Vaccine (Recombinant) Historical Market Size by Region (2016-2021) 2.3.1 Global Hepatitis B Vaccine (Recombinant) Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Hepatitis B Vaccine (Recombinant) Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Hepatitis B Vaccine (Recombinant) Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Region (2022-2027) 2.4.2 Global Hepatitis B Vaccine (Recombinant) Revenue Forecast by Region (2022-2027) 3 Global Hepatitis B Vaccine (Recombinant) Competitor Landscape by Players 3.1 Global Top Hepatitis B Vaccine (Recombinant) Manufacturers by Sales 3.1.1 Global Hepatitis B Vaccine (Recombinant) Sales by Manufacturer (2016-2021) 3.1.2 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Hepatitis B Vaccine (Recombinant) Manufacturers by Revenue 3.2.1 Key Hepatitis B Vaccine (Recombinant) Manufacturers Covered: Ranking by Revenue 3.2.2 Global Hepatitis B Vaccine (Recombinant) Revenue by Manufacturers (2016-2021) 3.2.3 Global Hepatitis B Vaccine (Recombinant) Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Hepatitis B Vaccine (Recombinant) Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Hepatitis B Vaccine (Recombinant) Revenue in 2020 3.2.6 Global Hepatitis B Vaccine (Recombinant) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Hepatitis B Vaccine (Recombinant) Price by Manufacturers 3.4 Global Hepatitis B Vaccine (Recombinant) Manufacturing Base Distribution, Product Types 3.4.1 Hepatitis B Vaccine (Recombinant) Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Hepatitis B Vaccine (Recombinant) Product Type 3.4.3 Date of International Manufacturers Enter into Hepatitis B Vaccine (Recombinant) Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Hepatitis B Vaccine (Recombinant) Market Size by Type (2016-2021) 4.1.1 Global Hepatitis B Vaccine (Recombinant) Sales by Type (2016-2021) 4.1.2 Global Hepatitis B Vaccine (Recombinant) Revenue by Type (2016-2021) 4.1.3 Hepatitis B Vaccine (Recombinant) Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Hepatitis B Vaccine (Recombinant) Market Size Forecast by Type (2022-2027) 4.2.1 Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Type (2022-2027) 4.2.2 Global Hepatitis B Vaccine (Recombinant) Revenue Forecast by Type (2022-2027) 4.2.3 Hepatitis B Vaccine (Recombinant) Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Hepatitis B Vaccine (Recombinant) Market Size by Application (2016-2021) 5.1.1 Global Hepatitis B Vaccine (Recombinant) Sales by Application (2016-2021) 5.1.2 Global Hepatitis B Vaccine (Recombinant) Revenue by Application (2016-2021) 5.1.3 Hepatitis B Vaccine (Recombinant) Price by Application (2016-2021) 5.2 Hepatitis B Vaccine (Recombinant) Market Size Forecast by Application (2022-2027) 5.2.1 Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Application (2022-2027) 5.2.2 Global Hepatitis B Vaccine (Recombinant) Revenue Forecast by Application (2022-2027) 5.2.3 Global Hepatitis B Vaccine (Recombinant) Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China Hepatitis B Vaccine (Recombinant) Market Size YoY Growth 2016-2027 6.1.1 China Hepatitis B Vaccine (Recombinant) Sales YoY Growth 2016-2027 6.1.2 China Hepatitis B Vaccine (Recombinant) Revenue YoY Growth 2016-2027 6.1.3 China Hepatitis B Vaccine (Recombinant) Market Share in Global Market 2016-2027 6.2 China Hepatitis B Vaccine (Recombinant) Market Size by Players (International and Local Players) 6.2.1 China Top Hepatitis B Vaccine (Recombinant) Players by Sales (2016-2021) 6.2.2 China Top Hepatitis B Vaccine (Recombinant) Players by Revenue (2016-2021) 6.3 China Hepatitis B Vaccine (Recombinant) Historic Market Review by Type (2016-2021) 6.3.1 China Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2016-2021) 6.3.2 China Hepatitis B Vaccine (Recombinant) Revenue Market Share by Type (2016-2021) 6.3.3 China Hepatitis B Vaccine (Recombinant) Price by Type (2016-2021) 6.4 China Hepatitis B Vaccine (Recombinant) Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China Hepatitis B Vaccine (Recombinant) Sales Forecast by Type (2022-2027) 6.4.2 China Hepatitis B Vaccine (Recombinant) Revenue Forecast by Type (2022-2027) 6.4.3 China Hepatitis B Vaccine (Recombinant) Price Forecast by Type (2022-2027) 6.5 China Hepatitis B Vaccine (Recombinant) Historic Market Review by Application (2016-2021) 6.5.1 China Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2016-2021) 6.5.2 China Hepatitis B Vaccine (Recombinant) Revenue Market Share by Application (2016-2021) 6.5.3 China Hepatitis B Vaccine (Recombinant) Price by Application (2016-2021) 6.6 China Hepatitis B Vaccine (Recombinant) Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China Hepatitis B Vaccine (Recombinant) Sales Forecast by Application (2022-2027) 6.6.2 China Hepatitis B Vaccine (Recombinant) Revenue Forecast by Application (2022-2027) 6.6.3 China Hepatitis B Vaccine (Recombinant) Price Forecast by Application (2022-2027) 7 North America 7.1 North America Hepatitis B Vaccine (Recombinant) Market Size YoY Growth 2016-2027 7.2 North America Hepatitis B Vaccine (Recombinant) Market Facts & Figures by Country 7.2.1 North America Hepatitis B Vaccine (Recombinant) Sales by Country (2016-2021) 7.2.2 North America Hepatitis B Vaccine (Recombinant) Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Hepatitis B Vaccine (Recombinant) Market Size YoY Growth 2016-2027 8.2 Asia Pacific Hepatitis B Vaccine (Recombinant) Market Facts & Figures by Region 8.2.1 Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Region (2016-2021) 8.2.2 Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Hepatitis B Vaccine (Recombinant) Market Size YoY Growth 2016-2027 9.2 Europe Hepatitis B Vaccine (Recombinant) Market Facts & Figures by Country 9.2.1 Europe Hepatitis B Vaccine (Recombinant) Sales by Country (2016-2021) 9.2.2 Europe Hepatitis B Vaccine (Recombinant) Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Hepatitis B Vaccine (Recombinant) Market Size YoY Growth 2016-2027 10.2 Latin America Hepatitis B Vaccine (Recombinant) Market Facts & Figures by Country 10.2.1 Latin America Hepatitis B Vaccine (Recombinant) Sales by Country (2016-2021) 10.2.2 Latin America Hepatitis B Vaccine (Recombinant) Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Facts & Figures by Country 11.2.1 Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Country (2016-2021) 11.2.2 Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 GSK 12.1.1 GSK Corporation Information 12.1.2 GSK Description and Business Overview 12.1.3 GSK Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021) 12.1.4 GSK Hepatitis B Vaccine (Recombinant) Products Offered 12.1.5 GSK Recent Development 12.2 Merck 12.2.1 Merck Corporation Information 12.2.2 Merck Description and Business Overview 12.2.3 Merck Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Merck Hepatitis B Vaccine (Recombinant) Products Offered 12.2.5 Merck Recent Development 12.3 Sanofi Pasteur 12.3.1 Sanofi Pasteur Corporation Information 12.3.2 Sanofi Pasteur Description and Business Overview 12.3.3 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Products Offered 12.3.5 Sanofi Pasteur Recent Development 12.4 Dynavax Technologies 12.4.1 Dynavax Technologies Corporation Information 12.4.2 Dynavax Technologies Description and Business Overview 12.4.3 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Products Offered 12.4.5 Dynavax Technologies Recent Development 12.5 LG Life Sciences 12.5.1 LG Life Sciences Corporation Information 12.5.2 LG Life Sciences Description and Business Overview 12.5.3 LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021) 12.5.4 LG Life Sciences Hepatitis B Vaccine (Recombinant) Products Offered 12.5.5 LG Life Sciences Recent Development 12.6 KM Biologics 12.6.1 KM Biologics Corporation Information 12.6.2 KM Biologics Description and Business Overview 12.6.3 KM Biologics Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021) 12.6.4 KM Biologics Hepatitis B Vaccine (Recombinant) Products Offered 12.6.5 KM Biologics Recent Development 12.7 Shenzhen Kangtai Biological Products 12.7.1 Shenzhen Kangtai Biological Products Corporation Information 12.7.2 Shenzhen Kangtai Biological Products Description and Business Overview 12.7.3 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Products Offered 12.7.5 Shenzhen Kangtai Biological Products Recent Development 12.8 Serum Institute 12.8.1 Serum Institute Corporation Information 12.8.2 Serum Institute Description and Business Overview 12.8.3 Serum Institute Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Serum Institute Hepatitis B Vaccine (Recombinant) Products Offered 12.8.5 Serum Institute Recent Development 12.11 GSK 12.11.1 GSK Corporation Information 12.11.2 GSK Description and Business Overview 12.11.3 GSK Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021) 12.11.4 GSK Hepatitis B Vaccine (Recombinant) Products Offered 12.11.5 GSK Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Hepatitis B Vaccine (Recombinant) Industry Trends 13.2 Hepatitis B Vaccine (Recombinant) Market Drivers 13.3 Hepatitis B Vaccine (Recombinant) Market Challenges 13.4 Hepatitis B Vaccine (Recombinant) Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Hepatitis B Vaccine (Recombinant) Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Hepatitis B Vaccine (Recombinant) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of 10mcg/0.5ml Table 3. Major Manufacturers of 10mcg/ml Table 4. Global Hepatitis B Vaccine (Recombinant) Market Size Growth Rate by Application (2021-2027) & (K Units) Table 5. Global Hepatitis B Vaccine (Recombinant) Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global Hepatitis B Vaccine (Recombinant) Sales by Regions (2016-2021) & (K Units) Table 7. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Regions (2016-2021) Table 8. Global Hepatitis B Vaccine (Recombinant) Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Region (2022-2027) & (K Units) Table 10. Global Hepatitis B Vaccine (Recombinant) Sales Market Share Forecast by Region (2022-2027) Table 11. Global Hepatitis B Vaccine (Recombinant) Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share Forecast by Region (2022-2027) Table 13. Global Hepatitis B Vaccine (Recombinant) Sales by Manufacturers (2016-2021) (K Units) Table 14. Global Hepatitis B Vaccine (Recombinant) Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top Hepatitis B Vaccine (Recombinant) Manufacturers by Revenue (US$ Million) in 2020 Table 16. Hepatitis B Vaccine (Recombinant) Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. Hepatitis B Vaccine (Recombinant) Revenue Share by Manufacturers (2016-2021) Table 18. Global Hepatitis B Vaccine (Recombinant) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global Hepatitis B Vaccine (Recombinant) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Vaccine (Recombinant) as of 2020) Table 20. Key Manufacturers Hepatitis B Vaccine (Recombinant) Price (2016-2021) (US$/Unit) Table 21. Hepatitis B Vaccine (Recombinant) Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Hepatitis B Vaccine (Recombinant) Product Type Table 23. Date of International Manufacturers Enter into Hepatitis B Vaccine (Recombinant) Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Hepatitis B Vaccine (Recombinant) Sales by Type (2016-2021) (K Units) Table 26. Global Hepatitis B Vaccine (Recombinant) Sales Share by Type (2016-2021) Table 27. Global Hepatitis B Vaccine (Recombinant) Revenue by Type (2016-2021) (US$ Million) Table 28. Global Hepatitis B Vaccine (Recombinant) Revenue Share by Type (2016-2021) Table 29. Hepatitis B Vaccine (Recombinant) Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 30. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Type (2022-2027) & (K Units) Table 31. Global Hepatitis B Vaccine (Recombinant) Sales Market Share Forecast by Type (2022-2027) Table 32. Global Hepatitis B Vaccine (Recombinant) Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share Forecast by Type (2022-2027) Table 34. Global Hepatitis B Vaccine (Recombinant) Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 35. Global Hepatitis B Vaccine (Recombinant) Sales by Application (2016-2021) (K Units) Table 36. Global Hepatitis B Vaccine (Recombinant) Sales Share by Application (2016-2021) Table 37. Global Hepatitis B Vaccine (Recombinant) Revenue by Application (2016-2021) (US$ Million) Table 38. Global Hepatitis B Vaccine (Recombinant) Revenue Share by Application (2016-2021) Table 39. Hepatitis B Vaccine (Recombinant) Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 40. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Application (2022-2027) & (K Units) Table 41. Global Hepatitis B Vaccine (Recombinant) Sales Market Share Forecast by Application (2022-2027) Table 42. Global Hepatitis B Vaccine (Recombinant) Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share Forecast by Application (2022-2027) Table 44. Global Hepatitis B Vaccine (Recombinant) Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 45. China Hepatitis B Vaccine (Recombinant) Sales (K Units) of Key Companies (2016-2021) Table 46. China Hepatitis B Vaccine (Recombinant) Sales Share by Company (2016-2021) Table 47. China Hepatitis B Vaccine (Recombinant) Revenue (US$ Million) by Company (2016-2021) Table 48. China Hepatitis B Vaccine (Recombinant) Revenue Share by Company (2016-2021) Table 49. China Hepatitis B Vaccine (Recombinant) Sales (K Units) by Type (2016-2021) Table 50. China Hepatitis B Vaccine (Recombinant) Sales Share by Type (2016-2021) Table 51. China Hepatitis B Vaccine (Recombinant) Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. China Hepatitis B Vaccine (Recombinant) Price (US$/Unit) by Type (2016-2021) Table 53. China Hepatitis B Vaccine (Recombinant) Sales (K Units) by Type (2022-2027) Table 54. China Hepatitis B Vaccine (Recombinant) Sales Share by Type (2022-2027) Table 55. China Hepatitis B Vaccine (Recombinant) Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. China Hepatitis B Vaccine (Recombinant) Revenue Share by Type (2022-2027) Table 57. China Hepatitis B Vaccine (Recombinant) Price (US$/Unit) by Type (2022-2027) Table 58. China Hepatitis B Vaccine (Recombinant) Sales (K Units) by Application (2016-2021) Table 59. China Hepatitis B Vaccine (Recombinant) Sales Share by Application (2016-2021) Table 60. China Hepatitis B Vaccine (Recombinant) Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. China Hepatitis B Vaccine (Recombinant) Price (US$/Unit) by Application (2016-2021) Table 62. China Hepatitis B Vaccine (Recombinant) Sales (K Units) by Application (2022-2027) Table 63. China Hepatitis B Vaccine (Recombinant) Sales Share by Application (2022-2027) Table 64. China Hepatitis B Vaccine (Recombinant) Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. China Hepatitis B Vaccine (Recombinant) Revenue Share by Application (2022-2027) Table 66. China Hepatitis B Vaccine (Recombinant) Price (US$/Unit) by Application (2022-2027) Table 67. North America Hepatitis B Vaccine (Recombinant) Sales by Country (2016-2021) & (K Units) Table 68. North America Hepatitis B Vaccine (Recombinant) Sales Market Share by Country (2016-2021) Table 69. North America Hepatitis B Vaccine (Recombinant) Revenue by Country (2016-2021) & (US$ Million) Table 70. North America Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Region (2016-2021) & (K Units) Table 72. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales Market Share by Region (2016-2021) Table 73. Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue Market Share by Region (2016-2021) Table 75. Europe Hepatitis B Vaccine (Recombinant) Sales by Country (2016-2021) & (K Units) Table 76. Europe Hepatitis B Vaccine (Recombinant) Sales Market Share by Country (2016-2021) Table 77. Europe Hepatitis B Vaccine (Recombinant) Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country (2016-2021) Table 79. Latin America Hepatitis B Vaccine (Recombinant) Sales by Country (2016-2021) & (K Units) Table 80. Latin America Hepatitis B Vaccine (Recombinant) Sales Market Share by Country (2016-2021) Table 81. Latin Americaa Hepatitis B Vaccine (Recombinant) Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Country (2016-2021) & (K Units) Table 84. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country (2016-2021) Table 87. GSK Corporation Information Table 88. GSK Description and Business Overview Table 89. GSK Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 90. GSK Hepatitis B Vaccine (Recombinant) Product Table 91. GSK Recent Development Table 92. Merck Corporation Information Table 93. Merck Description and Business Overview Table 94. Merck Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 95. Merck Product Table 96. Merck Recent Development Table 97. Sanofi Pasteur Corporation Information Table 98. Sanofi Pasteur Description and Business Overview Table 99. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 100. Sanofi Pasteur Product Table 101. Sanofi Pasteur Recent Development Table 102. Dynavax Technologies Corporation Information Table 103. Dynavax Technologies Description and Business Overview Table 104. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 105. Dynavax Technologies Product Table 106. Dynavax Technologies Recent Development Table 107. LG Life Sciences Corporation Information Table 108. LG Life Sciences Description and Business Overview Table 109. LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 110. LG Life Sciences Product Table 111. LG Life Sciences Recent Development Table 112. KM Biologics Corporation Information Table 113. KM Biologics Description and Business Overview Table 114. KM Biologics Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 115. KM Biologics Product Table 116. KM Biologics Recent Development Table 117. Shenzhen Kangtai Biological Products Corporation Information Table 118. Shenzhen Kangtai Biological Products Description and Business Overview Table 119. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 120. Shenzhen Kangtai Biological Products Product Table 121. Shenzhen Kangtai Biological Products Recent Development Table 122. Serum Institute Corporation Information Table 123. Serum Institute Description and Business Overview Table 124. Serum Institute Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 125. Serum Institute Product Table 126. Serum Institute Recent Development Table 127. Hepatitis B Vaccine (Recombinant) Market Trends Table 128. Hepatitis B Vaccine (Recombinant) Market Drivers Table 129. Hepatitis B Vaccine (Recombinant) Market Challenges Table 130. Hepatitis B Vaccine (Recombinant) Market Restraints Table 131. Hepatitis B Vaccine (Recombinant) Customers List Table 132. Hepatitis B Vaccine (Recombinant) Distributors List Table 133. Research Programs/Design for This Report Table 134. Key Data Information from Secondary Sources Table 135. Key Data Information from Primary Sources List of Figures Figure 1. Hepatitis B Vaccine (Recombinant) Product Picture Figure 2. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type in 2020 & 2027 Figure 3. 10mcg/0.5ml Product Picture Figure 4. 10mcg/ml Product Picture Figure 5. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application in 2020 & 2027 Figure 6. Newborn Figure 7. Adult Figure 8. Hepatitis B Vaccine (Recombinant) Report Years Considered Figure 9. Global Hepatitis B Vaccine (Recombinant) Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Hepatitis B Vaccine (Recombinant) Market Size 2016-2027 (US$ Million) Figure 11. Global Hepatitis B Vaccine (Recombinant) Sales 2016-2027 (K Units) Figure 12. Global Hepatitis B Vaccine (Recombinant) Market Size Market Share by Region: 2021 Versus 2027 Figure 13. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Region (2016-2021) Figure 14. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Region in 2020 Figure 15. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Region (2016-2021) Figure 16. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Region in 2020 Figure 17. Global Hepatitis B Vaccine (Recombinant) Sales Share by Manufacturer in 2020 Figure 18. The Top 10 and 5 Players Market Share by Hepatitis B Vaccine (Recombinant) Revenue in 2020 Figure 19. Hepatitis B Vaccine (Recombinant) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 20. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2016-2021) Figure 21. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type in 2020 Figure 22. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Type (2016-2021) Figure 23. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Type in 2020 Figure 24. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2016-2021) Figure 25. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application in 2020 Figure 26. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Application (2016-2021) Figure 27. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Application in 2020 Figure 28. China Hepatitis B Vaccine (Recombinant) Sales Growth Rate 2016-2027 (K Units) Figure 29. China Hepatitis B Vaccine (Recombinant) Revenue Growth Rate 2016-2027 (US$ Million) Figure 30. China Hepatitis B Vaccine (Recombinant) Market Share in Global Market 2016-2027 Figure 31. China 5 and 10 Largest Hepatitis B Vaccine (Recombinant) Players Market Share by Revenue in Hepatitis B Vaccine (Recombinant) in 2020 Figure 32. China Hepatitis B Vaccine (Recombinant) Revenue Share by Type (2016-2021) Figure 33. China Hepatitis B Vaccine (Recombinant) Revenue Growth Rate by Type in 2016 & 2020 Figure 34. China Hepatitis B Vaccine (Recombinant) Revenue Share by Application (2016-2021) Figure 35. China Hepatitis B Vaccine (Recombinant) Revenue Growth Rate by Application in 2016 & 2020 Figure 36. North America Hepatitis B Vaccine (Recombinant) Sales Growth Rate 2016-2021 (K Units) Figure 37. North America Hepatitis B Vaccine (Recombinant) Revenue Growth Rate 2016-2021 (US$ Million) Figure 38. North America Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2020 Figure 39. North America Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country in 2020 Figure 40. U.S. Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 41. U.S. Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Canada Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 43. Canada Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Europe Hepatitis B Vaccine (Recombinant) Sales Growth Rate 2016-2021 (K Units) Figure 45. Europe Hepatitis B Vaccine (Recombinant) Revenue Growth Rate 2016-2021 (US$ Million) Figure 46. Europe Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2020 Figure 47. Europe Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country in 2020 Figure 48. Germany Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 49. Germany Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. France Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 51. France Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. U.K. Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 53. U.K. Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. Italy Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 55. Italy Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. Russia Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 57. Russia Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales Growth Rate 2016-2021 (K Units) Figure 59. Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue Growth Rate 2016-2021 (US$ Million) Figure 60. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales Market Share by Region in 2020 Figure 61. Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue Market Share by Region in 2020 Figure 62. China Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 63. China Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 64. Japan Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 65. Japan Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 66. South Korea Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 67. South Korea Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. India Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 69. India Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. Australia Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 71. Australia Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. Taiwan Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 73. Taiwan Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Indonesia Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 75. Indonesia Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Thailand Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 77. Thailand Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Malaysia Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 79. Malaysia Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Philippines Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 81. Philippines Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Vietnam Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 83. Vietnam Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Latin America Hepatitis B Vaccine (Recombinant) Sales Growth Rate 2016-2021 (K Units) Figure 85. Latin America Hepatitis B Vaccine (Recombinant) Revenue Growth Rate 2016-2021 (US$ Million) Figure 86. Latin America Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2020 Figure 87. Latin America Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country in 2020 Figure 88. Mexico Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 89. Mexico Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 90. Brazil Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 91. Brazil Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 92. Argentina Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 93. Argentina Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales Growth Rate 2016-2021 (K Units) Figure 95. Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue Growth Rate 2016-2021 (US$ Million) Figure 96. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2020 Figure 97. Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country in 2020 Figure 98. Turkey Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 99. Turkey Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 100. Saudi Arabia Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 101. Saudi Arabia Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 102. UAE Hepatitis B Vaccine (Recombinant) Sales Growth Rate (2016-2021) (K Units) Figure 103. UAE Hepatitis B Vaccine (Recombinant) Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. Hepatitis B Vaccine (Recombinant) Value Chain Figure 105. Channels of Distribution Figure 106. Distributors Profiles Figure 107. Bottom-up and Top-down Approaches for This Report Figure 108. Data Triangulation Figure 109. Key Executives Interviewed

GSK Merck Sanofi Pasteur Dynavax Technologies LG Life Sciences KM Biologics Shenzhen Kangtai Biological Products Serum Institute